Disease × agent pairs

Lung Cancer: candidate agents with evidence

22 agents linked to Lung Cancer by at least one registered trial or two publications, ranked by the OSMF evidence score. Not treatment advice.

Sacituzumab Govitecan

Drug · tier A · 8 trials (3 recruiting) · 9 publications · score 76.5

Mitomycin

Drug · tier A · 8 trials (1 recruiting) · 11 publications · score 76.0

Olaparib

Drug · tier A · 8 trials (3 recruiting) · 11 publications · score 75.0

Carboplatin

Drug · tier A · 8 trials (1 recruiting) · 17 publications · score 74.0

Nicotine

Drug · tier A · 8 trials (0 recruiting) · 19 publications · score 74.0

Vinorelbine

Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 74.0

Gemcitabine

Drug · tier A · 8 trials (0 recruiting) · 17 publications · score 72.0

Oxaliplatin

Drug · tier A · 8 trials (3 recruiting) · 16 publications · score 70.5

Cisplatin

Drug · tier A · 8 trials (0 recruiting) · 17 publications · score 70.0

Bleomycin

Drug · tier A · 4 trials (1 recruiting) · 13 publications · score 62.0

Doxorubicin Hydrochloride

Drug · tier A · 8 trials (0 recruiting) · 5 publications · score 54.0

Talazoparib

Drug · tier A · 8 trials (0 recruiting) · 5 publications · score 51.5

Niraparib

Drug · tier A · 8 trials (1 recruiting) · 4 publications · score 51.0

Daunorubicin Hydrochloride

Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 48.0

Paclitaxel Protein-Bound

Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 46.0

Sirolimus

Drug · tier A · 8 trials (1 recruiting) · 5 publications · score 44.0

Rucaparib

Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 38.0

Tamoxifen Citrate

Drug · tier A · 4 trials (0 recruiting) · 0 publications · score 33.5

Resveratrol

Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 29.0

Dipyridamole

Drug · tier A · 0 trials (0 recruiting) · 4 publications · score 28.0

Mitoxantrone Hydrochloride

Drug · tier A · 2 trials (0 recruiting) · 0 publications · score 24.0

Riboflavin

Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 24.0

Research map, not treatment advice. Built 2026-11-22.